Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
基本信息
- 批准号:7591261
- 负责人:
- 金额:$ 29.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnthropometryBiologicalBody fatC-reactive proteinCellsChromatographyComplementComplexCore FacilityDataDetectionDevelopmentDiagnosticDigestionElectrospray IonizationFastingFatty acid glycerol estersFibrinogenFibrosisFunctional disorderGenesGenomicsGlucoseGlucose IntoleranceGoalsHepaticHigh PrevalenceHistologicHourHumanHyperinsulinismIndividualInflammationInjuryInsulinInsulin ResistanceInsulin-Like Growth-Factor Binding Protein 1Isotopically-Coded Affinity TaggingLaboratoriesLiquid ChromatographyLiverLiver diseasesMass Spectrum AnalysisMeasurementMeasuresMethodologyMethodsModelingModificationMorbidity - disease rateNon-Insulin-Dependent Diabetes MellitusObesityOxidative StressPatientsPeptidesPilot ProjectsPositioning AttributePrevalencePrincipal InvestigatorProtein AnalysisProteinsProteomeProteomicsPumpReportingReproducibilityResearch PersonnelResolutionRiskSamplingSecondary toSeveritiesSolventsSomatomedinsStagingSystemTechniquesTimeTissuesTwo-Dimensional Gel ElectrophoresisUnited StatesWorkbasecomparativeexperienceglucose metabolismglucose monitorhuman tissueimprovedindexinginnovationinsightinsulin sensitivityliver biopsymeetingsnon-alcoholic fatty livernonalcoholic steatohepatitisnovelprogramsprotein complexresearch studytandem mass spectrometrytooltrend
项目摘要
DESCRIPTION (provided by applicant): Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease in the United States. The high prevalence of NAFLD is largely on the basis of relentless increases in the prevalences of obesity and insulin resistance. The basis of progressive histological injury in a proportion of patients with NAFLD is poorly understood. The overall goals of this project are to 1) develop a model to identify patients with more histologically severe grades of NAFLD and 2) better define the pathophysiological basis of histological progression of NAFLD. Two hypotheses and specific aims have been developed to achieve these goals. Our first hypothesis is that indices of insulin sensitivity, hyperinsulinemia and/or subclinical inflammation can be used to generate a model capable of identifying patients at increased risk for more histologically severe grades of NAFLD. The first specific aim is to prospectively screen a panel of biological parameters for their ability to identify patients at risk for histologically severe NAFLD, as measured by NAFLD grade. In a pilot study of patients with varying degrees of severity of NAFLD, we found that more histologically severe NAFLD is independently associated with greater percent body fat, higher C-reactive protein and fasting insulin levels. Strong trends for an association with severity of NAFLD grade were also seen for higher IGFBP-1 levels, % truncal fat, HGH levels, and continuous glucose monitoring profiles. We now propose to carry out detailed assessments of these and other markers of subclinical inflammation, insulin sensitivity, insulin-like growth factor axis and assessments of anthropometry in patients with grades 1-3 of NAFLD and in controls. Our second hypothesis is that the inflammation and progressive fibrosis that can occur in NAFLD are substantially due to increased oxidative stress. The second specific aim is to determine the mechanism and effects of increased oxidative stress in NAFLD. Oxidative stress is thought to be central to hepatocellular injury in NAFLD. Our preliminary data demonstrate a possible pre-transcriptional basis of increased oxidative stress in patients with more histologically progressive NASH. In a logical extension of these experiments, we now propose to use high-throughput mass spectrometry analysis, using an ICAT tagging technique, to measure differential hepatic protein abundance, including of peroxisomal proteins, in patients with NAFLD grades 1-3, and also in controls. We believe that these experiments will generate mechanistic insight into the cause and effects of increased oxidative stress in patients with histologically progressive NAFLD.
描述(由申请人提供):非酒精性脂肪性肝病(NAFLD)是美国最常见的肝病形式。NAFLD的高患病率在很大程度上是基于肥胖和胰岛素抵抗患病率的持续增加。对一部分NAFLD患者进行性组织学损伤的基础知之甚少。该项目的总体目标是:1)开发一种模型,以识别组织学上更严重的NAFLD患者; 2)更好地定义NAFLD组织学进展的病理生理学基础。为实现这些目标,提出了两个假设和具体目标。我们的第一个假设是,胰岛素敏感性、高胰岛素血症和/或亚临床炎症的指数可用于生成能够识别组织学上更严重等级的NAFLD风险增加的患者的模型。第一个具体目标是前瞻性地筛选一组生物参数,以确定组织学上严重NAFLD风险的患者的能力,如通过NAFLD等级测量的。在一项针对不同严重程度NAFLD患者的初步研究中,我们发现组织学上更严重的NAFLD与更高的体脂百分比、更高的C反应蛋白和空腹胰岛素水平独立相关。IGFBP-1水平、躯干脂肪百分比、HGH水平和连续血糖监测曲线升高也与NAFLD严重程度相关。我们现在建议对这些和其他亚临床炎症标志物、胰岛素敏感性、胰岛素样生长因子轴进行详细评估,并对1-3级NAFLD患者和对照组进行人体测量评估。我们的第二个假设是,NAFLD中可能发生的炎症和进行性纤维化主要是由于氧化应激增加。第二个具体目标是确定NAFLD中氧化应激增加的机制和影响。氧化应激被认为是NAFLD肝细胞损伤的核心。我们的初步数据表明,在组织学进展性NASH患者中,氧化应激增加可能是转录前基础。在这些实验的逻辑延伸中,我们现在建议使用高通量质谱分析,使用ICAT标记技术,来测量NAFLD 1-3级患者和对照组的差异肝蛋白丰度,包括过氧化物酶体蛋白。我们相信,这些实验将产生机制洞察的原因和影响增加氧化应激患者组织学进展NAFLD。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hepatocyte tails.
肝细胞尾部。
- DOI:10.1016/j.cgh.2006.01.013
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Charlton,Michael
- 通讯作者:Charlton,Michael
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL R CHARLTON其他文献
MICHAEL R CHARLTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL R CHARLTON', 18)}}的其他基金
Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
- 批准号:
7035248 - 财政年份:2005
- 资助金额:
$ 29.37万 - 项目类别:
Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
- 批准号:
7391610 - 财政年份:2005
- 资助金额:
$ 29.37万 - 项目类别:
Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
- 批准号:
7211326 - 财政年份:2005
- 资助金额:
$ 29.37万 - 项目类别:
Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
- 批准号:
6859186 - 财政年份:2005
- 资助金额:
$ 29.37万 - 项目类别:
REDUCTION OF HCV RECURRANCE AFTER LIVER TRANSPLANTATION
减少肝移植后 HCV 复发
- 批准号:
2718450 - 财政年份:1998
- 资助金额:
$ 29.37万 - 项目类别:
THE ROLE GLUCAGON IN THE DISPOSAL OF AMINO ACIDS DURING AN AMINO ACID INFUSION
胰高血糖素在氨基酸输注过程中处理氨基酸的作用
- 批准号:
3763820 - 财政年份:
- 资助金额:
$ 29.37万 - 项目类别:
THE ROLE GLUCAGON IN THE DISPOSAL OF AMINO ACIDS DURING AN AMINO ACID INFUSION
胰高血糖素在氨基酸输注过程中处理氨基酸的作用
- 批准号:
3785879 - 财政年份:
- 资助金额:
$ 29.37万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 29.37万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 29.37万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 29.37万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 29.37万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 29.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 29.37万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 29.37万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 29.37万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 29.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 29.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists